Lung cancer in idiopathic pulmonary fibrosis

被引:0
|
作者
Kreider, Maryl [1 ]
机构
[1] Univ Penn, Perelman Sch Med, 0828 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA
关键词
Lung cancer; Idiopathic pulmonary fibrosis; Prevalence; Relativerisk; Riskfactors; Prognosis; Therapy; Acute exacerbation;
D O I
10.1007/s13665-013-0060-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Lung cancer appears to be more common among patients with idiopathic pulmonary fibrosis (IPF). The exact prevalence is unclear but is likely to be in the range 5-17 %. Risk factors for lung cancer in IPF include age, greater smoking history, and male gender. Squamous cell lung cancer may be more common in IPF than in the general population. The lung cancers are more often at the periphery and bases, although these findings are not universal. The pathogenesis behind this increased association is unknown but may be because of increased cell turnover and DNA damage. The development of lung cancer often is a late complication and the effect of this diagnosis on an individual's outcome is unknown. However, IPF affects patients' therapeutic options, both their ability to tolerate intervention and because of a significant risk of acute exacerbation after the intervention.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [41] Lung transplantation in idiopathic pulmonary fibrosis
    Kumar, Anupam
    Kapnadak, Siddhartha G.
    Girgis, Reda E.
    Raghu, Ganesh
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (05) : 375 - 385
  • [42] Lung Transplant in Idiopathic Pulmonary Fibrosis
    George, Timothy J.
    Arnaoutakis, George J.
    Shah, Ashish S.
    [J]. ARCHIVES OF SURGERY, 2011, 146 (10) : 1204 - 1209
  • [43] Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
    Kim, Ho Cheol
    Lee, Seonjeong
    Song, Jin Woo
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
    Kanayama, Masatoshi
    Mori, Masataka
    Matsumiya, Hiroki
    Taira, Akihiro
    Shinohara, Shinji
    Kuwata, Taiji
    Imanishi, Naoko
    Yoneda, Kazue
    Kuroda, Koji
    Tanaka, Fumihiro
    [J]. SURGERY TODAY, 2020, 50 (05) : 469 - 474
  • [45] Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
    Tzouvelekis, Argyris
    Gomatou, Georgia
    Bouros, Evangelos
    Trigidou, Rodoula
    Tzilas, Vasilios
    Bouros, Demosthenes
    [J]. CHEST, 2019, 156 (02) : 383 - 391
  • [46] Lung Cancer Incidence in Patients on Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
    Kadura, S.
    Barakat, A.
    Breeze, J.
    LaCamera, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Pneumopericardium in a patient with idiopathic pulmonary fibrosis and lung cancer undergoing chemotherapy
    Nakamura, Tomoaki
    Tani, Naoki
    Suzuki, Shinko
    [J]. BMJ CASE REPORTS, 2021, 14 (10)
  • [48] Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis
    Watanabe A.
    Miyajima M.
    Mishina T.
    Nakazawa J.
    Harada R.
    Kawaharada N.
    Higami T.
    [J]. General Thoracic and Cardiovascular Surgery, 2013, 61 (5) : 254 - 261
  • [49] Lung Cancer and Idiopathic Pulmonary Fibrosis From Epigenetics to drug therapy
    Tsitoura, Eliza
    Lasithiotaki, Ismini
    Vasarmidi, Eirini
    Sourvinos, George
    Antoniou, Katerina M.
    [J]. PNEUMON, 2015, 28 (01) : 23 - 25
  • [50] The Predictive Risk Factors for Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis
    Ikezoe, K.
    Handa, T.
    Tanizawa, K.
    Sokai, A.
    Nakatsuka, Y.
    Murase, Y.
    Kubo, T.
    Yoshizawa, A.
    Nagai, S.
    Chin, K.
    Hirai, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197